LA JOLLA PHARMACEUTICAL CO
LA JOLLA PHARMACEUTICAL CO (LJPC) is a publicly traded company in the Unknown sector. Across all available filings, 39 corporate insiders have executed 608 transactions totaling $221.3M, demonstrating a bullish sentiment with $183.4M in net insider flow. The most recent transaction on Aug 22, 2022 involved a transaction of 9,607,934 shares valued at $59.9M.
LJPC Insider Activity Summary
Who Is Buying LJPC Stock?
No significant insider buying has been recorded for LJPC in the recent period.
Who Is Selling LJPC Stock?
No significant insider selling has been recorded for LJPC in the recent period.
Is LA JOLLA PHARMACEUTICAL CO Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LJPC is bullish with an Insider Alignment Score of 91/100 and a net flow of $183.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
LJPC Frequently Asked Questions
Understanding LJPC Insider Activity
Insider trading at LA JOLLA PHARMACEUTICAL CO (LJPC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 39 insiders are actively trading LJPC stock, having executed 608 transactions in the past 90 days. The most active insider is Michael S. Hearne (Executive), who has made 49 transactions totaling $120.9M.
Related Tools
Track LA JOLLA PHARMACEUTICAL CO Insider Activity
Get notified when executives and directors at LJPC file new Form 4 transactions